S.TapertS
In the past, theyve been prescribed primarily to treat people with type 2 diabetes, but theyre now being used by a wider range of people for general weight loss, but also migraine and hormone management in some cases
Liu H, Zhou L, Wang H, Wang X, Qu G, Cai J, et al
With the market arrival of oral Wegovy and Orforglipron , the risk for Stevanato appears evident: If patients transition to oral GLP-1 formulations, Stevanato will see a decline in orders for its subcutaneous injection packaging solutions
During the shortage years, the GLP-1 market went wildfills for two GLP1-s, Wegovy and Zepbound, increased by 100% and 300%, respectively
I 2 = 8%) ( Figures 3AC )